Blank-Check Merger Values Genomic, Patient Data Biz At $2B
BlackRock-backed genomic and clinical data platform Sema4 announced plans Wednesday to go public through a merger with a blank-check company, in a deal steered by Fenwick & West and White &...To view the full article, register now.
Already a subscriber? Click here to view full article